Manager/Senior Manager, CMC Quality Control
Required skills
- CMC
- Quality Control
- gene therapy
- AAV
- cGMP
- analytical methods
- specifications
- release testing
- validation
- stability testing
Nice to have
- late-stage development
- process validation
- commercial readiness
- biologics
- cell therapy
- advanced therapeutics
Role summary
Lexeo is seeking a Manager/Senior Manager, CMC Quality Control to provide strategic and operational oversight for gene therapy programs. This role involves leading QC activities with external contract testing labs, managing analytical lifecycles, stability programs, and release testing. The individual will collaborate with cross-functional teams and external partners to ensure analytical methods and specifications meet clinical development and commercial requirements. Expertise in analytical testing, AAV-based products, and overseeing external labs is essential.
Role Summary
The Manager/Senior Manager, CMC Quality Control (QC) is responsible for providing strategic and operational oversight of QC activities supporting Lexeo's gene therapy programs. This role serves as a QC lead for external contract testing laboratories (CTLs), analytical lifecycle management (i.e., late-phase method validation), stability programs, release testing support, and analytical investigation activities.
The individual will work closely with Analytical Development, Technical Operations, Regulatory Affairs, Quality Assurance, and external partners to ensure analytical methods, specifications, and testing programs support clinical development, process validation readiness, and future commercial requirements.
This position requires technical expertise in analytical testing, preferably of AAV-based products, as well as demonstrated experience overseeing external laboratories and driving cross-functional CMC initiatives.
Primary Responsibilities
Required Skills and Qualifications
About LEXEO
Lexeo Therapeutics is a New York City-based, clinical stage company dedicated to reshaping the path of genetic disease. By advancing pioneering science, Lexeo seeks to set a new standard in the treatment of cardiovascular and neurological genetic diseases, charting the path to patient outcomes once thought out of reach. The Company is advancing a portfolio of therapeutic candidates designed to address the underlying genetic causes of disease, including LX2006 for Friedreich ataxia (FA), LX2020 for plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
Similar roles
- Scientist II, Cellular Neuroscience and Translational PharmacologyLexeo Therapeutics · New York, NY · Onsite
- Scientist II, Analytical DevelopmentLexeo Therapeutics · New York, NY · Onsite
Electrical Integration Quality Control Inspector - 2nd ShiftPanelmatic Inc. · Houston, TX · Onsite
Quality Controls Lab Operations Specialist (Overnights)Regeneron · Saratoga Springs, UT · Onsite
Quality Control InspectorCACI International Inc · Orlando, FL · Onsite- Senior Manager, Stability Management, Analytical Development and Quality ControlRevolution Medicines · Redwood City, CA · Hybrid
